CLINICAL AND LABORATORY FEATURES OF CHRONIC HEART FAILURE IN PATIENTS WITH METABOLIC SYNDROME
Keywords:
chronic heart failure, metabolic syndrome, echocardiographic parameters.Abstract
Chronic heart failure (CHF) is a major medical and social problem. The increase of morbidity results from both an increase of life expectancy of the population, and influence of various risk factors contributing to development and increase of heart failure. The combination of several atherogenic mechanisms (abdominal obesity, insulin resistance, arterial hypertension, hyperglycemia, dyslipidemia), combined as «metabolic syndrome» (MS), causes a more rapid development of CHF.
References
Atakhodzhaeva G.A., Mal G.S., Mirzalieva A.A. Dynamics of left ventricular remodeling indicators during combination therapy of chronic heart failure and metabolic syndrome// Tibbiyotda yangi kun. -2020.-3(31).pp.695-700.
GA Atakhodjaeva, SM Rakhimov, NZ Azimova. Heart rate variability in patients with chronic heart failure and metabolic syndrome//Likars’kasprava, 2017; 3-4 pp. 31-37
Early diagnosis and adequate treatment of patients with cor pulmonale/ A.L.Alyavi , D.A. Rakhimova, Z.T. Sabirzhanova// Ukrainian therapeutic journal. -2017.-№ 1.P. 27-32.
A.L.Alyavi , D.A. Rakhimova, Z.T. Sabirzhanova, Yu.Kh. Tadzhikhodzhaeva, M.Kh.Nazirova. Diastolic function of the right ventricle of the heart in the dynamics of the effects of various treatment regimens in patients with chronic obstructive pulmonary disease// Eurasian Cardiological Magazine.2016.№.3.pp/195-196.
McMurray J.J., Adamopoulos S., Anker S.D. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic HF 2012: The task force for the diagnosis and treatment of acute and chronic HF in collaboration with the HF European Society of Cardiology // Eur. Heart J. 2012. Vol. 33. № 14. P. 1787–1847.
Kannel W.B. Incidence and epidemiology of heart failure // Heart Fail. Rev. 2000. Vol. 5. № 2. P. 167–173.
Horwich T.B., Patel J., MacLellan W.R., Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure // Circulation. 2003. Vol. 108. № 7. P. 833–838.
Drapkina O.M., Ivashkin V.T., Korneeva O.N. Clinical variants of metabolic syndrome.M.: Medical Information Agency, 2012. pp.36-59, 65-68.
Perrone-Filardi P., Paolillo S., Costanzo P. et al. The role of metabolic syndrome in heart failure // Eur. Heart J. 2015. Vol. 36. № 39. P. 2630–2634.
Kochegura T.N., Makarevich P.I., Ovchinnikov A.G. et al. Circulating factors associated with metabolic disorders in patients with post-infarction heart failure//Journal“HeartFailure”.2013.T.4.№.4(78).pp.191-199
Fukuta H., Ohte N., Wakami K. et al. Relation of plasma levels of adiponectin to left ventricular diastolic dysfunction in patients undergoing cardiac catheterization for coronary artery disease // Am. J. Cardiol. 2011. Vol. 108. № 8. P. 1081–1085.
Roitman A.P., Fedorova T.A., Ivanova E.A. and others. The role of metabolic disorders, inflammation, myocardial damage in the development of chronic heart failure in patients with metabolic syndrome// Laboratory Service.2018.T.7.№.4.P.5-10.
Fedorova T.A., Semenenko N.A., Ivanova E.A. and others. Highly sensitive troponin I and apolipoproteins in assessing the severity and predicting the course of chronic heart failure // Russian National Congress of Cardiologists - 2018. M.: Federal State Budgetary Educational Institution of Higher Education “First Moscow State Medical University named Sechenov" Ministry of Health of the Russian Federation, 2018. P. 869.
Fedorova T.A., Semenenko N.A., Ivanova E.A. and others. Highly sensitive troponin I and apolipoproteins in assessing the severity and predicting the course of chronic heart failure// Russian National Congress of Cardiologists-2018.M.:Federal State Budgertary Educational Institution of Higher Education “First Moscow State Medical University named Sechenov” Ministry of Health of the Russian Federation,2018.P.869
Gombos T., Förhécz Z., Pozsonyi Z. et al. Long-term survival and apolipoprotein A1 level in chronic heart failure: interaction with tumor necrosis factor α-308 G/A polymorphism // J. Card. Fail. 2017. Vol. 23. № 2. P. 113–120.
Downloads
Published
Versions
- 2023-11-15 (2)
- 2023-11-01 (1)